SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001539497-23-001177
Filing Date
2023-06-30
Accepted
2023-06-30 16:31:33
Documents
10
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 PRE 14A n3660_x1-pre14a.htm PRE 14A 269048
2 GRAPHIC n3660_x1-pre14aaimg001.jpg GRAPHIC 11681
3 GRAPHIC n3660_x1-pre14aaimg002.jpg GRAPHIC 7663
4 GRAPHIC n3660_x1-pre14aaimg003.jpg GRAPHIC 7052
5 GRAPHIC n3660_x1-pre14aaimg004.jpg GRAPHIC 2406
6 GRAPHIC n3660_x1-pre14aaimg005.jpg GRAPHIC 7669
7 GRAPHIC n3660_x1-pre14aaimg006.jpg GRAPHIC 1838
8 GRAPHIC n3660_x1-pre14aaimg007.jpg GRAPHIC 7453
9 GRAPHIC n3660_x1-pre14aaimg008.jpg GRAPHIC 376151
10 GRAPHIC n3660_x1-pre14aaimg009.jpg GRAPHIC 276298
  Complete submission text file 0001539497-23-001177.txt   1233135
Mailing Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729
Business Address 9301 AMBERGLEN BLVD SUITE 100 AUSTIN TX 78729 512 896 1555
Molecular Templates, Inc. (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-32979 | Film No.: 231062225
SIC: 2834 Pharmaceutical Preparations